CNSP - CNS Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
Total Revenue
0
0
Cost of Revenue
-
-
Gross Profit
-
-
Operating Expenses
Research Development
370
21
Selling General and Administrative
1,148
861
Total Operating Expenses
1,518
882
Operating Income or Loss
-1,518
-882
Interest Expense
55
47
Total Other Income/Expenses Net
-
-6,463
Income Before Tax
-7,981
-7,392
Income Tax Expense
-
-
Income from Continuing Operations
-7,981
-7,392
Net Income
-7,981
-7,392
Net Income available to common shareholders
-7,981
-7,392
Reported EPS
Basic
-
-0.47
Diluted
-
-0.47
Weighted average shares outstanding
Basic
-
15,712
Diluted
-
15,712
EBITDA
-
-7,345